Post-Doctoral Fellowship

Fellowship at Wade Berrettini's lab at the University of Pennsylvania to study functional implications of a risk haplotype for nicotine addiction, in a recently awarded 5 year NIH grant. The risk haplotype spans the alpha 5 and alpha 3 nicotinic receptor subunit genes on chromosome 15. The identified risk haplotype also conveys risk for lung cancer and chronic obstructive pulmonary disease. Planned experiments include use of third generation sequencing technologies, in vitro cell culture assays and allelic imbalance studies of post mortem human brain. Interested applicants should send cv's to wadeb@mail.med.upenn.edu.
Sponsor(s): University of Pennsylvania, NIH
Application Date(s): Beginning January 1, 2010

Clinical Research Manager

Johns Hopkins University Nuclear Medicine/High Resolution Brain PET Imaging

VA Research Psychiatrist

University of California San Francisco